What are the major opportunities in the cancer biomarker market? What are the strategies for the cancer biomarker market?

For detailed insights on the major opportunities and strategies in the cancer biomarker market, Read More

How does the cancer biomarker market relate to the overall economy and other similar markets?

For detailed insights on cancer biomarker market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the cancer biomarker market growth? SWOT analysis of the cancer biomarker market.

For detailed insights on the key dynamics influencing the cancer biomarker market growth and SWOT analysis of the cancer biomarker industry, Read More

Cancer Biomarker Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Cancer Biomarker Market Report 2026

Name: Cancer Biomarker Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Profiling Technologies (Omics Technologies, Immunoassay, Bioinformatics, Cytogenetics), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cancer Biomarker Market Overview

• Cancer Biomarker market size has reached to $25.09 billion in 2025

• Expected to grow to $52.63 billion in 2030 at a compound annual growth rate (CAGR) of 16%

• Growth Driver: The Surging Incidence Of Cancer Fueling Growth In The Cancer Biomarker Market

• Market Trend: Advancements In AI-Powered Cancer Biomarkers: Enhancing Diagnosis And Treatment Precision

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Biomarker Market?

A cancer biomarker refers to a biological molecule present in the blood, tissues, or other bodily fluids, that indicates the presence of normal or abnormal activity, as well as a condition or disease. Cancer biomarkers are used to characterize alterations in the tumor.

The main types of cancer biomarker are protein biomarkers, genetic biomarkers, and other that uses omics technologies, imaging technologies, immunoassay, bioinformatics, and cytogenetics profiling technologies. Protein biomarkers refer to detectable flags in a patient's blood that corresponds with significant events or signal distinct states in a biological process, such as disease progression. Protein biomarkers are used to perform accurate disease diagnosis. The cancer biomarker is used in various cancer such as breast cancer, lung cancer, colorectal cancer, prostate cancer, thyroid cancer, kidney cancer, and other cancers. It is used in diagnostics, research and development, prognostics, risk assessment, and other applications.

Cancer Biomarker market report bar graph

What Is The Cancer Biomarker Market Size and Share 2026?

The cancer biomarker market size has grown rapidly in recent years. It will grow from $25.09 billion in 2025 to $29.07 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to increasing cancer prevalence worldwide, advancements in molecular biology research, expansion of oncology research funding, rising adoption of biomarker-based diagnostics, improvements in imaging and assay technologies.

What Is The Cancer Biomarker Market Growth Forecast?

The cancer biomarker market size is expected to see rapid growth in the next few years. It will grow to $52.63 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing demand for personalized oncology treatments, rising investments in precision medicine, expansion of biomarker-driven drug development, growing use of ai-based biomarker analysis, increasing focus on early-stage cancer screening. Major trends in the forecast period include increasing use of genetic and protein biomarkers, rising adoption of companion diagnostics, growing integration of omics technologies, expansion of liquid biopsy applications, enhanced focus on early cancer detection.

Book your 30 minutes free consultation with our research experts

Global Cancer Biomarker Market Segmentation

1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types

2) By Profiling Technologies: Omics Technologies, Immunoassay, Bioinformatics, Cytogenetics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Protein

2) By Genetic Biomarkers: DNA Mutations, RNA Expression Profiles

3) By Other Biomarker Types: Epigenetic Biomarkers, Metabolomic Biomarkers

What Is The Driver Of The Cancer Biomarker Market?

The rising incidence of cancer is driving the growth of the cancer biomarker market. The cancer incidence rate is the number of new cancers of a specific site/type that occur in a given population during a given year, represented as cancers per 100,000 people at risk. The increasing incidence of cancer is leading to the widespread use of cancer biomarkers because it helps in assessing disease risk, screening for occult primary tumors, identifying benign from malignant signs, or separating one form of malignancy from another. Cancer biomarkers help in the early detection, diagnosis, and monitoring of cancer by indicating the presence or progression of the disease, enabling personalized treatment and improving patient outcomes. For instance, in May 2024, according to a report published by the International Agency for Research on Cancer (IARC), a France-based cancer research organization, in 2022, approximately 20 million new cancer cases were reported, resulting in 9.7 million deaths, by 2050, over 35 million new cancer cases are projected, representing a 77% increase compared to 2022. Therefore, the rising incidence of cancer packaging is expected to propel the growth of the cancer biomarker industry in the coming years.

Key Players In The Global Cancer Biomarker Market

Major companies operating in the cancer biomarker market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc.

Global Cancer Biomarker Market Trends and Insights

Major companies operating in the cancer biomarker market are focusing on developing innovative solutions, such as AI-powered cancer biomarkers, to enhance diagnostic accuracy and personalize treatment plans for patients. AI-powered cancer biomarkers refer to biological indicators of cancer that are identified and analyzed using artificial intelligence technologies. For instance, in September 2023, Ibex Medical Analytics, a US-based Ibex Medical Analytics, launched Galen Breast HER2, an AI-powered solution designed to enhance the accuracy and reproducibility of HER2 scoring in breast cancer patients. This innovative platform aids pathologists by automatically detecting invasive tumor areas and quantifying HER2 expression based on the 2018 ASCO/CAP guidelines. The Galen Breast HER2 system utilizes a novel computational pipeline to analyze immunohistochemistry (IHC)-stained slides, providing detailed visualizations of staining patterns and enabling pathologists to make informed treatment decisions.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cancer Biomarker Market?

In June 2025, Illumina Inc., a U.S.-based genomics/sequencing technology company, acquired SomaLogic Inc. for US$ 350 million (plus up to US$ 75 million in performance-based milestones). With this acquisition, Illumina aims to accelerate its multi-omics strategy by integrating high-throughput proteomics (biomarker) capabilities into its sequencing platform. SomaLogicInc. a US-based clinical diagnostics company, specializes in proteomics and has developed a powerful protein-biomarker discovery platform (SomaScan) for research and disease-profiling.

Regional Outlook

North America was the largest region in the cancer biomaker market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cancer Biomarker Market?

The cancer biomarker market consists of sales of epigenetic biomarkers, and metabolic biomarkers for various cancers such as melanoma, leukemia, bladder cancer, non-hodgkin's lymphoma, endometrial cancer, pancreatic cancer, and liver cancer. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cancer Biomarker Market Report 2026?

The cancer biomarker market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer biomarker industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cancer Biomarker Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$29.07 billion
Revenue Forecast In 2035	$52.63 billion
Growth Rate	CAGR of 15.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Biomarker Type, Profiling Technologies, Cancer Type, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc., Sysmex Corporation, Biocartis Group NV, NanoString Technologies Inc., Veracyte Inc., Epic Sciences Inc., Cynvenio Biosystems Inc., Genomic Health Inc., Oncocyte Corporation, Exosome Diagnostics Inc., Grail Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cancer Biomarker Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cancer Biomarker Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cancer Biomarker Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cancer Biomarker Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Genetic And Protein Biomarkers

4.2.2 Rising Adoption Of Companion Diagnostics

4.2.3 Growing Integration Of Omics Technologies

4.2.4 Expansion Of Liquid Biopsy Applications

4.2.5 Enhanced Focus On Early Cancer Detection

5. Cancer Biomarker Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Research Institutes

5.4 Pharmaceutical Companies

5.5 Biotechnology Firms

6. Cancer Biomarker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cancer Biomarker Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cancer Biomarker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cancer Biomarker Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cancer Biomarker Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cancer Biomarker Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cancer Biomarker Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cancer Biomarker Market Segmentation

9.1. Global Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types

9.2. Global Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Omics Technologies, Immunoassay, Bioinformatics, Cytogenetics

9.3. Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers

9.4. Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

9.5. Global Cancer Biomarker Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor-Specific Antigens, Circulating Tumor Protein

9.6. Global Cancer Biomarker Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Mutations, RNA Expression Profiles

9.7. Global Cancer Biomarker Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Epigenetic Biomarkers, Metabolomic Biomarkers

10. Cancer Biomarker Market Regional And Country Analysis

10.1. Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cancer Biomarker Market

11.1. Asia-Pacific Cancer Biomarker Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cancer Biomarker Market

12.1. China Cancer Biomarker Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cancer Biomarker Market

13.1. India Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cancer Biomarker Market

14.1. Japan Cancer Biomarker Market Overview

14.2. Japan Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cancer Biomarker Market

15.1. Australia Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cancer Biomarker Market

16.1. Indonesia Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cancer Biomarker Market

17.1. South Korea Cancer Biomarker Market Overview

17.2. South Korea Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cancer Biomarker Market

18.1. Taiwan Cancer Biomarker Market Overview

18.2. Taiwan Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cancer Biomarker Market

19.1. South East Asia Cancer Biomarker Market Overview

19.2. South East Asia Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cancer Biomarker Market

20.1. Western Europe Cancer Biomarker Market Overview

20.2. Western Europe Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cancer Biomarker Market

21.1. UK Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cancer Biomarker Market

22.1. Germany Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cancer Biomarker Market

23.1. France Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cancer Biomarker Market

24.1. Italy Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cancer Biomarker Market

25.1. Spain Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cancer Biomarker Market

26.1. Eastern Europe Cancer Biomarker Market Overview

26.2. Eastern Europe Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cancer Biomarker Market

27.1. Russia Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cancer Biomarker Market

28.1. North America Cancer Biomarker Market Overview

28.2. North America Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cancer Biomarker Market

29.1. USA Cancer Biomarker Market Overview

29.2. USA Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cancer Biomarker Market

30.1. Canada Cancer Biomarker Market Overview

30.2. Canada Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cancer Biomarker Market

31.1. South America Cancer Biomarker Market Overview

31.2. South America Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cancer Biomarker Market

32.1. Brazil Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cancer Biomarker Market

33.1. Middle East Cancer Biomarker Market Overview

33.2. Middle East Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cancer Biomarker Market

34.1. Africa Cancer Biomarker Market Overview

34.2. Africa Cancer Biomarker Market, Segmentation By Biomarker Type, Segmentation By Profiling Technologies, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cancer Biomarker Market Regulatory and Investment Landscape

36. Cancer Biomarker Market Competitive Landscape And Company Profiles

36.1. Cancer Biomarker Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cancer Biomarker Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cancer Biomarker Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cancer Biomarker Market Other Major And Innovative Companies

Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., Bristol-Myers Squibb Company, PerkinElmer Inc., Siemens AG, Exact Sciences Corporation, Novartis AG, Agilent Technologies Inc., Hologic Inc., Myriad Genetics Inc., Foundation Medicine Inc., Guardant Health Inc., Natera Inc.

38. Global Cancer Biomarker Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cancer Biomarker Market

40. Cancer Biomarker Market High Potential Countries, Segments and Strategies

40.1 Cancer Biomarker Market In 2030 - Countries Offering Most New Opportunities

40.2 Cancer Biomarker Market In 2030 - Segments Offering Most New Opportunities

40.3 Cancer Biomarker Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cancer Biomarker Market, Overview Of Key Products - Product Examples

Table 2: Global Cancer Biomarker Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cancer Biomarker Market, Supply Chain Analysis

Table 4: Global Cancer Biomarker Market, Major Raw Material Providers

Table 5: Global Cancer Biomarker Market, Major Resource Providers

Table 6: Global Cancer Biomarker Market, Major Manufacturers (Suppliers)

Table 7: Global Cancer Biomarker Market, Major Distributors And Channel Partners

Table 8: Global Cancer Biomarker Market, Key Technologies & Future Trends

Table 9: Global Cancer Biomarker Market, Major Trends

Table 10: Global Cancer Biomarker Market, Major End Users

Table 11: Global Cancer Biomarker Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cancer Biomarker Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cancer Biomarker Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cancer Biomarker Market - TAM, US$ Billion, 2025

Table 15: Global Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cancer Biomarker Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cancer Biomarker Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cancer Biomarker Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Cancer Biomarker Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Cancer Biomarker Market - Company Scoring Matrix

Table 98: F. Hoffmann-La Roche AG Financial Performance

Table 99: Thermo Fisher Scientific Inc. Financial Performance

Table 100: QIAGEN NV Financial Performance

Table 101: Illumina Inc. Financial Performance

Table 102: Bio-Rad Laboratories Inc. Financial Performance

Table 103: Global Cancer Biomarker Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Cancer Biomarker Market, Competitive Dashboard

Table 105: Global Cancer Biomarker Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Cancer Biomarker Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Table 107: Global, Cancer Biomarker Market Size Gain ($ Billion), Segmentation By Profiling Technologies, 2025 – 2030

Table 108: Global, Cancer Biomarker Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

List Of Figures

Figure 1: Global Cancer Biomarker Market, Overview Of Key Products - Product Examples

Figure 2: Global Cancer Biomarker Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cancer Biomarker Market, Supply Chain Analysis

Figure 4: Global Cancer Biomarker Market, Major Raw Material Providers

Figure 5: Global Cancer Biomarker Market, Major Resource Providers

Figure 6: Global Cancer Biomarker Market, Major Manufacturers (Suppliers)

Figure 7: Global Cancer Biomarker Market, Major Distributors And Channel Partners

Figure 8: Global Cancer Biomarker Market, Key Technologies & Future Trends

Figure 9: Global Cancer Biomarker Market, Major Trends

Figure 10: Global Cancer Biomarker Market, Major End Users

Figure 11: Global Cancer Biomarker Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cancer Biomarker Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cancer Biomarker Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cancer Biomarker Market - TAM, US$ Billion, 2025

Figure 15: Global Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cancer Biomarker Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cancer Biomarker Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cancer Biomarker Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cancer Biomarker Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cancer Biomarker Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Cancer Biomarker Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Cancer Biomarker Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Cancer Biomarker Market, Segmentation By Profiling Technologies, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Cancer Biomarker Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Cancer Biomarker Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Cancer Biomarker Market - Company Scoring Matrix

Figure 98: F. Hoffmann-La Roche AG Financial Performance

Figure 99: Thermo Fisher Scientific Inc. Financial Performance

Figure 100: QIAGEN NV Financial Performance

Figure 101: Illumina Inc. Financial Performance

Figure 102: Bio-Rad Laboratories Inc. Financial Performance

Figure 103: Global Cancer Biomarker Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Cancer Biomarker Market, Competitive Dashboard

Figure 105: Global Cancer Biomarker Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Cancer Biomarker Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Figure 107: Global, Cancer Biomarker Market Size Gain ($ Billion), Segmentation By Profiling Technologies, 2025 – 2030

Figure 108: Global, Cancer Biomarker Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030

Global 3D Bioprinting Market Projected to Reach $5.04 Billion by 2029 at a CAGR of 23.1%

$15.02 Billion Forecast for AI-based Surgical Robots Market by 2029, Backed by Demand and Innovation

Arrhythmia Monitoring Devices Market Forecast Reaching $12.03 Billion by 2029 at 10.2% CAGR

Autoinjectors Market Valuation Expected To Reach $9.93 Billion By 2029, Growing At A Rate Of 21.8%

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Air-Dried Food Market Report 2026 - Global Outlook – By Product (Fruits And Vegetables, Herbs And Spices, Meat And Seafood, Other Products), By Form (Powder, Granules, Flakes), By Distribution Channel (Supermarkets And H...

Epoxy Composite Market Report 2026 - Global Outlook – By Fiber Type (Glass Fiber, Carbon Fiber, Other Fiber Types), By Manufacturing Process (Lay-up, Compression Molding, Resin Injection, Resin Transfer Molding, Filament...

Orthopedic Surgical Robots Market Report 2026 - Global Outlook – By Product (Robotic System, Robotic Accessories, Software And Services), By Application (Partial Knee Replacement, Total Knee Replacement, Minimally Invasi...

Optical Microscopes Market Report 2026 - Global Outlook – By Product (Digital Microscopes, Stereo Microscope, Inverted Microscopes, Other Products), By Application (Aerospace, Construction, Power Industry, Medical, Other...

Hydroelectric Cells Market Report 2026 - Global Outlook – By Metal Oxide ( Tin(IV) Oxide (SnO,, Aluminum Oxide (AI2O,, Zinc Oxide (ZnO), Titanium Dioxide (TiO,, Magnesium Oxide (MgO), Silicon Dioxide (SiO,), By Applicati...

Automotive Smart Key Market Report 2026 - Global Outlook – By Type (Passive Key Less Access, Remote Key Less Access), By Installation (OEM, After Market), By Application (Single Function, Multi-Function) – Market Size, T...

Frequently Asked Questions

How big is the Cancer Biomarker Market?

The Cancer Biomarker market was valued at $25.09 billion in 2025, increased to $29.07 billion in 2026, and is projected to reach $52.63 billion by 2030.

What is the Cancer Biomarker market growth?

The global Cancer Biomarker market is expected to grow at a CAGR of 16.0% from 2026 to 2035 to reach $52.63 billion by 2035.

Who are the key players in Cancer Biomarker market?

Some Key Players in the Cancer Biomarker market Include, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., QIAGEN NV, Illumina Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, bioMérieux SA, Becton Dickinson and Company, Merck & Co. Inc., B

Major trend in this market includes: Advancements In AI-Powered Cancer Biomarkers: Enhancing Diagnosis And Treatment Precision. For further insights on this market. request a sample here

North America was the largest region in the cancer biomaker market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biomarker market report are Asia-Pacific, South E

Book your 30 minutes free consultation with our research experts

Contact Us